Dr. Reddy’s launches OTC PPI for heartburn

Consumer

Dr. Reddy’s Laboratories Ltd has launched Lansoprazole Delayed-Release Capsules USP, 15 mg, an over-the-counter store-brand equivalent of Prevacid® 24HR Capsules (Prevacid® is a registered trademark of Takeda Pharmaceuticals North America, Inc) in the US market with FDA approval. Dr. Reddy’s OTC Proton Pump Inhibitor is for the treatment of recurring heartburn that a patient might suffer two or more days a week, and comes in packets of 14, 28 and 42.

“Dr. Reddy’s launches OTC PPI for heartburn“

Milan Kalawadia, SVP and Head of US OTC and Specialty Rx Divisions, Dr. Reddy’s Laboratories, said: "We are pleased to continue to expand our antacids and PPI portfolio for our customers. We look forward to collaborating with our customers to provide high-quality, affordable alternatives to consumers.”

See all the latest jobs in Consumer
Return to news